6-Shogaol, an active constituent of ginger, attenuates neuroinflammation and cognitive deficits in animal models of dementia

2014 ◽  
Vol 449 (1) ◽  
pp. 8-13 ◽  
Author(s):  
Minho Moon ◽  
Hyo Geun Kim ◽  
Jin Gyu Choi ◽  
Hyein Oh ◽  
Paula KJ Lee ◽  
...  
2017 ◽  
Vol 795 ◽  
pp. 13-21 ◽  
Author(s):  
Mahboubeh Zarezadeh ◽  
Tourandokht Baluchnejadmojarad ◽  
Zahra Kiasalari ◽  
Siamak Afshin-Majd ◽  
Mehrdad Roghani

2009 ◽  
Vol 206 (4) ◽  
pp. 631-640 ◽  
Author(s):  
Brian Villumsen Broberg ◽  
Birte Yding Glenthøj ◽  
Rebecca Dias ◽  
Dorrit Bjerg Larsen ◽  
Christina Kurre Olsen

2017 ◽  
Vol 8 (3) ◽  
pp. 1323-1332 ◽  
Author(s):  
Xu Rui ◽  
Li Wenfang ◽  
Cheng Jing ◽  
Chen Meng ◽  
Ding Chengcheng ◽  
...  

Accumulating epidemiological and experimental studies have confirmed that a high-cholesterol diet is detrimental to cognitive performance in animal models.


2019 ◽  
Vol 20 (10) ◽  
pp. 2405 ◽  
Author(s):  
Jakub Hort ◽  
Martin Vališ ◽  
Kamil Kuča ◽  
Francesco Angelucci

Vascular cognitive impairment (VCI) is the second most common cause of cognitive deficit after Alzheimer’s disease. Since VCI patients represent an important target population for prevention, an ongoing effort has been made to elucidate the pathogenesis of this disorder. In this review, we summarize the information from animal models on the molecular changes that occur in the brain during a cerebral vascular insult and ultimately lead to cognitive deficits in VCI. Animal models cannot effectively represent the complex clinical picture of VCI in humans. Nonetheless, they allow some understanding of the important molecular mechanisms leading to cognitive deficits. VCI may be caused by various mechanisms and metabolic pathways. The pathological mechanisms, in terms of cognitive deficits, may span from oxidative stress to vascular clearance of toxic waste products (such as amyloid beta) and from neuroinflammation to impaired function of microglia, astrocytes, pericytes, and endothelial cells. Impaired production of elements of the immune response, such as cytokines, and vascular factors, such as insulin-like growth factor 1 (IGF-1), may also affect cognitive functions. No single event could be seen as being the unique cause of cognitive deficits in VCI. These events are interconnected, and may produce cascade effects resulting in cognitive impairment.


2014 ◽  
Vol 121 (5) ◽  
pp. 1219-1231 ◽  
Author(s):  
Samuel S. Shin ◽  
C. Edward Dixon ◽  
David O. Okonkwo ◽  
R. Mark Richardson

Traumatic brain injury (TBI) remains a significant public health problem and is a leading cause of death and disability in many countries. Durable treatments for neurological function deficits following TBI have been elusive, as there are currently no FDA-approved therapeutic modalities for mitigating the consequences of TBI. Neurostimulation strategies using various forms of electrical stimulation have recently been applied to treat functional deficits in animal models and clinical stroke trials. The results from these studies suggest that neurostimulation may augment improvements in both motor and cognitive deficits after brain injury. Several studies have taken this approach in animal models of TBI, showing both behavioral enhancement and biological evidence of recovery. There have been only a few studies using deep brain stimulation (DBS) in human TBI patients, and future studies are warranted to validate the feasibility of this technique in the clinical treatment of TBI. In this review, the authors summarize insights from studies employing neurostimulation techniques in the setting of brain injury. Moreover, they relate these findings to the future prospect of using DBS to ameliorate motor and cognitive deficits following TBI.


Sign in / Sign up

Export Citation Format

Share Document